Results and discussion
At least five caspases, including caspase-3, are expressed in human keratinocytes [5] . To determine whether caspase-3 becomes activated during human keratinocyte differentiation, we used affinity-purified CM1 rabbit antibodies that specifically recognize the cleaved, activated form of caspase-3 but not uncleaved procaspase-3 [6] . When used to immunostain newborn human foreskin, the antibodies reproducibly stained patches of cells at the transition zone between the granular and cornified layers of the epidermis (Figure 1a,b) , suggesting that procaspase-3 is activated late during keratinocyte differentiation.
To investigate whether caspase activation is required for normal keratinocyte differentiation, we used a culture system in which newborn human foreskin keratinocytes are grown on a matrix of denatured human dermis at an air-liquid interface to generate a remarkably normal looking epidermis [7, 8] . This reconstituted epidermis stained similarly to normal foreskin with the CM1 antibodies (Figure 1c reconstituted epidermis were stained with propidium iodide to visualize cell nuclei, the reconstituted epidermis was usually of normal thickness, but in most regions the cell nuclei failed to flatten and were maintained in the most superficial epidermal layers (Figure 2c,d ). By contrast, reconstituted epidermis developed normally in untreated cultures (data not shown) and in cultures treated with an inhibitor of the non-caspase protease cathepsin-B -benzyloxycarboxyl-Phe-Ala(O-methyl)-fluoromethylketone (zFA-fmk) (Figure 2a,b) . The caspase inhibitors did not block all aspects of differentiation, however, as keratinocytes still became flattened in the upper layers of reconstituted epidermis treated with zVAD-fmk or BocD-fmk. These results suggest that caspase activation is required for some aspects of keratinocyte differentiation, such as nuclear loss, but not for others.
Nucleated keratinocytes are often seen in the cornified layers of the epidermis under conditions in which the keratinocytes proliferate excessively. To determine whether the caspase inhibitors influence cell proliferation, we used Ki67 antibodies to stain proliferating cells in frozen sections of reconstituted epidermis [8] . In three separate experiments the proportions of proliferating cells were 17 ± 4% (mean ± standard deviation) in untreated cultures, 17 ± 1% in cultures treated with the caspase inhibitor BocD-fmk, and 19 ± 5% in cultures treated with the cathepsin-B inhibitor zFA-fmk. Moreover, in all of these conditions, Ki67-labelled cells were confined to the basal layer (data not shown). Thus, neither the proportion of proliferating cells nor their location was affected by the caspase inhibitors.
To confirm that some caspases are activated during normal epidermal differentiation, we made cytosolic extracts of normal foreskin epidermis and tested their ability to cleave the fluorogenic peptide caspase substrate z-Asp-Glu-ValAsp-aminotrifluoromethylcoumarin (zDEVD-AFC), as previously described [9] . This peptide is efficiently cleaved by caspase-3 and its close relatives [4] . In extracts of the two samples of foreskin epidermis tested, we detected cleavage activity that was comparable to that detected in an extract of freshly dissociated rat thymocytes, where 5% of the cells were apoptotic (as determined by propidium iodide staining). When expressed in picomoles of zDEVD-AFC per hour per µg protein [9] , one epidermis sample had a specific activity of 6.5, the other of 10.6, and the thymocytes had a specific activity of 6.9. These findings are consistent with the staining pattern seen with the CM1 antibodies in Figure 1a and the conclusion that caspase-3 (and/or related caspases) is activated during normal keratinocyte differentiation.
We also used CM1 antibodies to probe western blots of extracts of cultured keratinocytes and foreskin epidermis. When we studied keratinocyte and foreskin extracts, the CM1 antibodies revealed a faint doublet of around 25 kDa ( Figure 3a ), but as expected [6] , did not recognize any bands of the size expected for procaspase-3 (30 kDa) ( Figure 3a ). It is likely that the doublet represents cleaved caspase-3, as it was greatly enhanced in keratinocytes that had been induced to undergo apoptosis by treatment with 5 µM staurosporine and 10 µg/ml cycloheximide [10] . In addition, the doublet levels were reduced when the staurosporine-and cycloheximide-treated keratinocytes were pretreated with BocD-fmk ( Figure 3a ). When we induced keratinocytes to differentiate and form squames at an air-liquid interface, the CM1 antibodies again detected a similar doublet, the intensity of which was reduced in cultures treated with BocD-fmk ( Figure 3b ). The BocD-fmk treatment did not affect the levels of procaspase-3 ( Figure 3b ). Taken together, these findings support the conclusion that at least one caspase is cleaved during keratinocyte differentiation.
To assess the effects of the caspase inhibitors on another aspect of keratinocyte differentiation, we stained frozen sections of reconstituted epidermis with a monoclonal antibody that recognizes the intermediate-filament-associated protein filaggrin and its large precursor, profilaggrin, which normally accumulates in keratohyalin granules in the granular layer of the epidermis (reviewed in [1] ). In the upper regions of the granular layer, the profilaggrin is cleaved into smaller filaggrin molecules, which decorate the surface of the keratin filaments, causing the filaments to aggregate [1] and giving the filaggrin staining a fibrillar appearance (Figure 4a ). Profilaggrin cleavage precedes nuclear degradation [11] , and it plays an important part in the reorganization of the cytoskeleton that accompanies the formation of the cornified envelope [1] . The pattern of anti-filaggrin staining was similar in normal foreskin epidermis and reconstituted epidermis that had developed in the presence of the cathepsin-B inhibitor zFA-fmk (compare Figure 4a with 4c) . It was distinctly different, however, in reconstituted epidermis that had developed in the presence of caspase inhibitors: in this case the filaggrin staining was greatly reduced and exclusively granular (Figure 4e ). It is possible, therefore, that caspases may be required, either directly or indirectly, for profilaggrin processing.
In summary, our findings suggest that keratinocyte differentiation is accompanied by the activation of procaspase-3 and that the activation of at least one caspase is required for both nuclear loss and normal filaggrin processing. It remains to be determined which caspases are required for these aspects of keratinocyte differentiation. The terminal differentiation of a keratinocyte is not simply apoptosis, however, because the outcome is very different from that of classical apoptosis, where the cell usually shrinks, frequently fragments, and is rapidly phagocytosed and digested [3, 12, 13] .
It has been shown recently that caspases are also involved in lens cell differentiation [14] : some caspases become activated when rodent lens epithelial cells terminally differentiate into anucleate lens fibers in vivo, and a caspase inhibitor blocks the denucleation process in vitro. In addition, in Drosophila oogenesis, an inactivating mutation in a Brief Communication 363
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Effects on filaggrin expression of treatment with a caspase inhibitor. caspase gene prevents the cytoskeletal reorganization and nuclear breakdown that normally occurs when nurse cells transfer their cytoplasmic contents into a developing oocyte [15] . Thus, there is increasing evidence that caspases are involved in those differentiation processes that are associated with organelle loss. The results of caspase activation in these circumstances are clearly different from classical apoptosis. The challenge now is to understand the molecular bases of these differences.
Materials and methods

Keratinocyte culture
Normal human keratinocytes were isolated from neonatal foreskin epidermis (strain kb, passage 4) and cultured on a feeder layer of J2-3T3 cells in FAD medium as described previously [16] . Reconstituted epidermis was produced by culturing the keratinocytes on de-epidermized human dermis (DED; prepared from normal adult abdominal skin) with some modifications [8] . Cells were cultured submerged for a week, and then raised to an air-liquid interface to promote keratinocyte terminal differentiation for another week. In some experiments, a peptide caspase inhibitor, zVAD-fmk or BocD-fmk, or the cathepsin-B inhibitor zFA-fmk was added the day after seeding (final concentration 200 µM) and again with every medium change for 2 weeks.
Immunohistochemistry
Affinity-purified CM1 rabbit antibodies (kindly supplied by Anu Srinivasan, Idun Pharmaceuticals) were raised against, and purified on, a 13 amino-acid peptide corresponding to the carboxyl terminus of the large (p20) subunit of activated human caspase-3 [6] . The mouse monoclonal anti-human filaggrin antibody was purchased from Biomedical Technologies. Normal human foreskin (from 11 or 39 day old infants) or reconstituted epidermis were fixed in 4% paraformaldehyde and stained by indirect immunofluorescence. All sections were doublelabeled with propidium iodide (1 µg/ml) to visualize the nuclei. The stained sections were examined in an MRC-1000 laser-scanning fluorescence confocal microscope. About six consecutive 1 µm optical sections were summed to give a single fluorescence image, and a transmitted-light confocal image of the same field was then recorded.
Cytosolic extracts, caspase activity and western blots
Extracts of foreskin epidermis were prepared and assayed for enzymatic activity as previously described, using zDEVD-AFC (Enzyme Systems Products) as substrate [9] .
Supplementary material
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Immunohistochemistry
Specimens were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer pH 7.4 for up to a day. The tissue was then incubated in 1 M sucrose in the same buffer at 4°C overnight, embedded in OCT/1 M sucrose solution (1:1, v:v) for at least 6 h with gentle shaking at room temperature, snap-frozen in liquid nitrogen, and stored at -20°C. For filaggrin staining, the tissue was left unfixed and treated as follows: 1 M sucrose for 2 h at 4°C, frozen at -20°C, thawed at 4°C, and then embedded in OCT/sucrose solution as above. Frozen tissue was cut into 8 µm sections on a cryostat. Unfixed sections were fixed in methanol for 10 min. All sections were incubated for 1 h in blocking buffer (10% normal goat serum (NGS), 0.4% Triton X-100 in phosphate-buffered saline (PBS)) at room temperature and then for 1 h in antibodies diluted in incubation buffer (2% NGS, 0.4% Triton X-100 in PBS). The sections were washed three times with 0.1% Tween 20 in PBS, and the bound CM1 antibodies were detected with biotinylated anti-rabbit immunoglobulin antibodies (Amersham), followed by streptavidin-FITC (Amersham).
The anti-filaggrin antibodies were detected with Cy5-conjugated goat anti-mouse antibodies (Jackson Laboratories). The stained sections were examined using an MRC-1000 laser-scanning fluorescence confocal microscope. About six consecutive 1 µm optical sections were summed to give a single fluorescence-image, and a transmitted-light confocal image of the same field was then recorded.
Western blot assays
The foreskin epidermis and reconstituted epidermis were removed from the dermis and DED, respectively, by treatment with 2.5 mg/ml dispase (Boehringer Mannheim) as described previously [S1]. Confluent cultures of human foreskin keratinocytes were treated for 5 h with 5 µM staurosporine and 10 µg/ml cycloheximide, with or without 200 µM BocD-fmk, or in medium alone. The epidermis or cultured keratinocytes were dissolved in SDS-PAGE sample buffer containing β-mercaptoethanol. Protein concentrations were measured in microtiter plates using a Coomassie plus or BCA protein assay kit (Pierce), and the samples were stored at -80°C. The samples (100 µg each) and molecular weight markers were run on 15% SDS-PAGE gels and transferred to PVDF membranes using a semi-dry transfer apparatus (Hoeffer Transblot). Western blotting was performed using the CM1 antibodies, the affinity-purified rabbit antibodies against procaspase-3 [S2], and the mouse monoclonal anti-actin antibody (ICN) as loading control. The blots were developed using the Pierce Chemiluminescence substrate according to the manufacturer's instructions.
Cytosolic extracts
Foreskin epidermis (isolated as above) was rinsed in cold PBS, quickly blotted in tissue paper and transfered immediately into ice-cold buffer A (20 mM Hepes-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM Na EDTA, 1 mM Na EGTA, 1 mM dithiothreitol), supplemented with protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 5 µg/ml pepstatin A, 10 µg/ml leupeptin, 2 µg/ml aprotinin, and 25 µg/ml n-acetyl-Leu-Leunorleucinal). The tissue was chopped into smaller pieces in this buffer, and cytosolic extracts were prepared as previously described [S3] .
Caspase activity
To detect the activity of caspase-3 and closely related caspases, 5-10 µg of thymocyte or 50 µg of foreskin epidermis extract were incubated with the substrate zDEVD-AFC (Enzyme Systems Products) as described previously [S3] . The amount of cleaved zDEVD-AFC in each of three aliquots from each sample was measured (Perkin Elmer LS 50B; excitation at 400 nm and emission at 505 nm), and the specific activity of caspases was calculated [S3] .
